Harmony Biosciences Ownership

Some institutional investors establish a significant position in stocks such as Harmony Biosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Harmony Biosciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Check out Risk vs Return Analysis.

Harmony Ownership Allocation 

 
Refresh
Preferred Dividends Income Statement Impact is likely to rise to about 27.1 M in 2021. Issuance Purchase of Equity Shares is likely to rise to about 159.4 M in 2021, whereas Weighted Average Shares is likely to drop slightly above 21.7 M in 2021.
Harmony Biosciences secures a total of 56.9 Million outstanding shares. The majority of Harmony Biosciences outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Harmony Biosciences to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Harmony Biosciences Holdings. Please pay attention to any change in the institutional holdings of Harmony Biosciences as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Harmony Stock Ownership Analysis

About 19.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania. Harmony Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 150 people. To learn more about Harmony Biosciences Holdings call the company at 484 539 9800 or check out http://www.harmonybiosciences.com.

Harmony Biosciences SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Harmony Biosciences prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Harmony Biosciences investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Harmony Biosciences specific information freely available to individual and institutional investors to make a timely investment decision.
10th of August 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
View
12th of July 2021
Unclassified Corporate Event
View
15th of June 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
19th of February 2021
Other Events
View

Harmony Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Harmony Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Harmony Biosciences Holdings backward and forwards among themselves. Harmony Biosciences' institutional investor refers to the entity that pools money to purchase Harmony Biosciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fmr LlcCommon Shares4.9 M139.5 M
Vivo Capital LlcCommon Shares4.5 M128 M
Venbio Partners LlcCommon Shares3.5 M98.9 M
Newlight Partners LpCommon Shares2.7 M75.3 M
Novo Holdings ACommon Shares1.4 M40.2 M
Blackrock IncCommon Shares1.3 M36.8 M
Janus Henderson Group PlcCommon Shares1.3 M35.6 M
Note, although Harmony Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Harmony Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harmony Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harmony Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Harmony Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Dayno Jeffrey M over a week ago via Macroaxis 
Exercise or conversion by Dayno Jeffrey M of 1800 shares of Harmony Biosciences subject to Rule 16b-3
Dayno Jeffrey M over a week ago via Macroaxis 
Exercise or conversion by Dayno Jeffrey M of 10000 shares of Harmony Biosciences subject to Rule 16b-3
Jacobs John C over a month ago via Macroaxis 
Exercise or conversion by Jacobs John C of 25000 shares of Harmony Biosciences subject to Rule 16b-3
Dierks Jeffrey over a month ago via Macroaxis 
Exercise or conversion by Dierks Jeffrey of 917 shares of Harmony Biosciences subject to Rule 16b-3
Dierks Jeffrey over a month ago via Macroaxis 
Exercise or conversion by Dierks Jeffrey of 10000 shares of Harmony Biosciences subject to Rule 16b-3
Dierks Jeffrey over a month ago via Macroaxis 
Exercise or conversion by Dierks Jeffrey of 3400 shares of Harmony Biosciences subject to Rule 16b-3
Dayno Jeffrey M over two months ago via Macroaxis 
Exercise or conversion by Dayno Jeffrey M of 9950 shares of Harmony Biosciences subject to Rule 16b-3
Dayno Jeffrey M over two months ago via Macroaxis 
Exercise or conversion by Dayno Jeffrey M of tradable shares of Harmony Biosciences subject to Rule 16b-3
Dierks Jeffrey over three months ago via Macroaxis 
Exercise or conversion by Dierks Jeffrey of 15000 shares of Harmony Biosciences subject to Rule 16b-3
Dierks Jeffrey over three months ago via Macroaxis 
Acquisition by Dierks Jeffrey of 53900 shares of Harmony Biosciences subject to Rule 16b-3
Motley Eric L over three months ago via Macroaxis 
Acquisition by Motley Eric L of 7246 shares of Harmony Biosciences subject to Rule 16b-3
Kapadia Sandip over six months ago via Macroaxis 
Acquisition by Kapadia Sandip of 230000 shares of Harmony Biosciences subject to Rule 16b-3

Be your own money manager

Our tools can tell you how much better you can do entering a position in Harmony Biosciences without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Harmony Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Risk vs Return Analysis. Note that the Harmony Biosciences information on this page should be used as a complementary analysis to other Harmony Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Tools for Harmony Stock

When running Harmony Biosciences price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go